{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,6]],"date-time":"2024-08-06T07:54:13Z","timestamp":1722930853856},"reference-count":17,"publisher":"Wiley","issue":"12","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":3574,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1111\/j.1368-5031.2005.00708.x","type":"journal-article","created":{"date-parts":[[2005,11,18]],"date-time":"2005-11-18T23:38:25Z","timestamp":1132357105000},"page":"1387-1394","source":"Crossref","is-referenced-by-count":15,"title":["Achieving lipid goals in real life: the Dutch DISCOVERY Study"],"prefix":"10.1155","volume":"59","author":[{"given":"A. F. E.","family":"Bots","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. J. P.","family":"Kastelein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"on behalf of the discovery netherlands investigators","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2005,11,18]]},"reference":[{"key":"10.1111\/j.1368-5031.2005.00708.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1053\/euhj.1998.1243","article-title":"Prevention of coronary heart disease in clinical practice: recommendations of the Second Joint Task Force of European and other Societies on coronary prevention","volume":"19","author":"Wood","year":"1998","journal-title":"Eur Heart J"},{"key":"10.1111\/j.1368-5031.2005.00708.x-BIB2|cit2","first-page":"2092","article-title":"Behandeling en preventie van coronaire hartziekten door verlaging van de serumcholesterolconcentratie; derde consensus \u2018Cholesterol\u2019","volume":"142","author":"Simoons","year":"1998","journal-title":"Ned Tijdschr Geneeskd"},{"key":"10.1111\/j.1368-5031.2005.00708.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1001\/jama.285.19.2486","article-title":"Executive Summary of the Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)","volume":"285","author":"Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults.","year":"2001","journal-title":"JAMA"},{"issue":"Suppl. 1","key":"10.1111\/j.1368-5031.2005.00708.x-BIB4|cit4","first-page":"S2","article-title":"European guidelines on cardiovascular disease prevention in clinical practice: third joint task force of European and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of eight societies and by invited experts)","volume":"10","author":"De Backer","year":"2003","journal-title":"Eur J Cardiovasc Prev Rehabil"},{"key":"10.1111\/j.1368-5031.2005.00708.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1053\/euhj.2001.2610","article-title":"Lifestyle and risk factor management and use of drug therapies in coronary patients from 15 countries; principal results from EUROASPIRE II Euro Heart Survey Programme","volume":"22","author":"EUROASPIRE II Study Group.","year":"2001","journal-title":"Eur Heart J"},{"key":"10.1111\/j.1368-5031.2005.00708.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1046\/j.1365-2125.2003.01769.x","article-title":"Undertreatment of hypercholesterolaemia: a population-based study","volume":"55","author":"Mantel-Teeuwisse","year":"2003","journal-title":"Br J Clin Pharmacol"},{"key":"10.1111\/j.1368-5031.2005.00708.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"11C","DOI":"10.1016\/S0002-9149(03)00004-3","article-title":"Guidelines for lowering lipids to reduce coronary heart disease risk: a comparison of rosuvastatin with atorvastatin, pravastatin, and simvastatin for achieving lipid-lowering goals","volume":"91","author":"Shepherd","year":"2003","journal-title":"Am J Cardiol"},{"key":"10.1111\/j.1368-5031.2005.00708.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/S0002-9149(03)00530-7","article-title":"Comparison of the efficacy and safety of rosuvastatin versus atorvastatin, simvastatin, and pravastatin across doses (STELLAR Trial)","volume":"92","author":"Jones","year":"2003","journal-title":"Am J Cardiol"},{"key":"10.1111\/j.1368-5031.2005.00708.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.ahj.2003.10.004","article-title":"Effects of switching statins on achievement of lipid goals: Measuring Effective Reductions in Cholesterol Using Rosuvastatin Therapy (MERCURY I) study","volume":"147","author":"Schuster","year":"2004","journal-title":"Am Heart J"},{"key":"10.1111\/j.1368-5031.2005.00708.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1016\/j.clinthera.2004.11.015","article-title":"Twelve-week, multicenter, randomized, open-label comparison of the effects of rosuvastatin 10 mg\/d and atorvastatin 10 mg\/d in high-risk adults: a DISCOVERY study","volume":"26","author":"Strandberg","year":"2004","journal-title":"Clin Ther"},{"issue":"Suppl. A","key":"10.1111\/j.1368-5031.2005.00708.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"A12","DOI":"10.1016\/j.ehjsup.2004.01.004","article-title":"Reducing low-density lipoprotein cholesterol - treating to target and meeting new European goals","volume":"6","author":"Kritharides","year":"2004","journal-title":"Eur Heart J Suppl"},{"key":"10.1111\/j.1368-5031.2005.00708.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/S0002-9149(01)01727-1","article-title":"Effect of rosuvastatin on low-density lipoprotein cholesterol in patients with hypercholesterolemia","volume":"88","author":"Olsson","year":"2001","journal-title":"Am J Cardiol"},{"key":"10.1111\/j.1368-5031.2005.00708.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1067\/mhj.2002.128049","article-title":"Effects of rosuvastatin and atorvastatin compared over 52 weeks of treatment in patients with hypercholesterolemia","volume":"144","author":"Olsson","year":"2002","journal-title":"Am Heart J"},{"key":"10.1111\/j.1368-5031.2005.00708.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1067\/mhj.2002.129312","article-title":"Efficacy and safety of rosuvastatin compared with pravastatin and simvastatin in patients with hypercholesterolemia: a randomized, double-blind, 52-week trial","volume":"144","author":"Brown","year":"2002","journal-title":"Am Heart J"},{"key":"10.1111\/j.1368-5031.2005.00708.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"3051","DOI":"10.1161\/CIRCULATIONAHA.105.555482","article-title":"The safety of rosuvastatin as used in common clinical practice","volume":"111","author":"Alsheikh","year":"2005","journal-title":"Circulation"},{"key":"10.1111\/j.1368-5031.2005.00708.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"3016","DOI":"10.1161\/CIRCULATIONAHA.105.557652","article-title":"The issue of statin safety. Where do we stand?","volume":"111","author":"Grundy","year":"2005","journal-title":"Circulation"},{"key":"10.1111\/j.1368-5031.2005.00708.x-BIB17|cit17","unstructured":"Department of Health and Human Services. http:\/\/www.fda.gov\/cder\/drug\/infopage\/rosuvastatin\/crestor_CP.pdf"}],"container-title":["International Journal of Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1368-5031.2005.00708.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1368-5031.2005.00708.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,28]],"date-time":"2022-01-28T06:05:56Z","timestamp":1643349956000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1368-5031.2005.00708.x"}},"subtitle":["Achieving lipid goals"],"short-title":[],"issued":{"date-parts":[[2005,11,18]]},"references-count":17,"journal-issue":{"issue":"12"},"URL":"https:\/\/doi.org\/10.1111\/j.1368-5031.2005.00708.x","relation":{},"ISSN":["1368-5031"],"issn-type":[{"type":"print","value":"1368-5031"}],"subject":[],"published":{"date-parts":[[2005,11,18]]}}}